Stage IIIB Breast Cancer Terminated Phase 2 Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01868503Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast CancerTreatment